Matrone Gianfranco, Wilson Kathryn S, Maqsood Sana, Mullins John J, Tucker Carl S, Denvir Martin A
British Heart Foundation Centre for Cardiovascular Science, The Queen's Medical Research Institute, The University of Edinburgh, Edinburgh EH16 4TJ, UK Center for Cardiovascular Regeneration, Department of Cardiovascular Sciences, Methodist Hospital Research Institute, Houston, TX 77030, USA.
British Heart Foundation Centre for Cardiovascular Science, The Queen's Medical Research Institute, The University of Edinburgh, Edinburgh EH16 4TJ, UK.
J Cell Sci. 2015 Dec 15;128(24):4560-71. doi: 10.1242/jcs.175018. Epub 2015 Nov 5.
Cyclin dependent kinase (Cdk)9 acts through the positive transcription elongation factor-b (P-TEFb) complex to activate and expand transcription through RNA polymerase II. It has also been shown to regulate cardiomyocyte hypertrophy, with recent evidence linking it to cardiomyocyte proliferation. We hypothesised that modification of CDK9 activity could both impair and enhance the cardiac response to injury by modifying cardiomyocyte proliferation. Cdk9 expression and activity were inhibited in the zebrafish (Danio rerio) embryo. We show that dephosphorylation of residue Ser2 on the C-terminal domain of RNA polymerase II is associated with impaired cardiac structure and function, and cardiomyocyte proliferation and also results in impaired functional recovery following cardiac laser injury. In contrast, de-repression of Cdk9 activity, through knockdown of La-related protein (Larp7) increases phosphorylation of Ser2 in RNA polymerase II and increases cardiomyocyte proliferation. Larp7 knockdown rescued the structural and functional phenotype associated with knockdown of Cdk9. The balance of Cdk9 and Larp7 plays a key role in cardiomyocyte proliferation and response to injury. Larp7 represents a potentially novel therapeutic target to promote cardiomyocyte proliferation and recovery from injury.
细胞周期蛋白依赖性激酶(Cdk)9通过正性转录延伸因子b(P-TEFb)复合物发挥作用,以激活并扩展RNA聚合酶II介导的转录。研究还表明,它可调节心肌细胞肥大,最近有证据将其与心肌细胞增殖联系起来。我们推测,改变CDK9的活性可能通过改变心肌细胞增殖来损害和增强心脏对损伤的反应。在斑马鱼(Danio rerio)胚胎中抑制了Cdk9的表达和活性。我们发现,RNA聚合酶II C末端结构域上的丝氨酸2(Ser2)残基去磷酸化与心脏结构和功能受损、心肌细胞增殖有关,并且还导致心脏激光损伤后功能恢复受损。相反,通过敲低La相关蛋白(Larp7)来解除对Cdk9活性的抑制,会增加RNA聚合酶II中Ser2的磷酸化,并增加心肌细胞增殖。敲低Larp7可挽救与敲低Cdk9相关的结构和功能表型。Cdk9和Larp7的平衡在心肌细胞增殖和对损伤的反应中起关键作用。Larp7代表了一个潜在的新型治疗靶点,可促进心肌细胞增殖和从损伤中恢复。